These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 21139094)

  • 21. Variation in use of dual-chamber implantable cardioverter-defibrillators: results from the national cardiovascular data registry.
    Matlock DD; Peterson PN; Wang Y; Curtis JP; Reynolds MR; Varosy PD; Masoudi FA
    Arch Intern Med; 2012 Apr; 172(8):634-41; discussion 641. PubMed ID: 22529229
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cost-effectiveness of implantable cardioverter defibrillators in patients >or=65 years of age.
    Sanders GD; Kong MH; Al-Khatib SM; Peterson ED
    Am Heart J; 2010 Jul; 160(1):122-31. PubMed ID: 20598982
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R; Porter CB; Ackerman MJ
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival after implantable cardioverter-defibrillator implantation in the elderly.
    Yung D; Birnie D; Dorian P; Healey JS; Simpson CS; Crystal E; Krahn AD; Khaykin Y; Cameron D; Chen Z; Lee DS
    Circulation; 2013 Jun; 127(24):2383-92. PubMed ID: 23775193
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of the main implantable cardioverter-defibrillator trials in clinical practice: data from the Italian ICD Registry for the years 2005-07.
    Proclemer A; Ghidina M; Gregori D; Facchin D; Rebellato L; Fioretti P; Brignole M
    Europace; 2009 Apr; 11(4):465-75. PubMed ID: 19136490
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Variation among hospitals in selection of higher-cost, "higher-tech," implantable cardioverter-defibrillators: data from the National Cardiovascular Data Registry (NCDR) Implantable Cardioverter/Defibrillator (ICD) Registry.
    Lampert R; Wang Y; Curtis JP
    Am Heart J; 2013 Jun; 165(6):1015-1023.e2. PubMed ID: 23708175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcomes and costs of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death among the elderly.
    Groeneveld PW; Farmer SA; Suh JJ; Matta MA; Yang F
    Heart Rhythm; 2008 May; 5(5):646-53. PubMed ID: 18452864
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy.
    Verma A; Sarak B; Kaplan AJ; Oosthuizen R; Beardsall M; Wulffhart Z; Higenbottam J; Khaykin Y
    Pacing Clin Electrophysiol; 2010 Mar; 33(3):320-9. PubMed ID: 19796352
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geriatric Conditions in Patients Undergoing Defibrillator Implantation for Prevention of Sudden Cardiac Death: Prevalence and Impact on Mortality.
    Green AR; Leff B; Wang Y; Spatz ES; Masoudi FA; Peterson PN; Daugherty SL; Matlock DD
    Circ Cardiovasc Qual Outcomes; 2016 Jan; 9(1):23-30. PubMed ID: 26715650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preventing sudden death: implantable cardioverter-defibrillators in elderly cardiac patients.
    Groeneveld PW
    LDI Issue Brief; 2008; 13(6):1-4. PubMed ID: 18613344
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spanish implantable cardioverter-defibrillator registry. 5th official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2008).
    Peinado R; Torrecilla EG; Ormaetxe J; Alvarez M; Cózar R; Alzueta J;
    Rev Esp Cardiol; 2009 Dec; 62(12):1435-49. PubMed ID: 20038409
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Trends in hospitalization for the implantation of cardioverter-defibrillators in the United States, 1990-2005.
    Brown DW; Croft JB; Greenlund KJ; Mensah GA; Giles WH
    Am J Cardiol; 2008 Jun; 101(12):1753-5. PubMed ID: 18549853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dual-chamber implantable cardioverter-defibrillator selection is associated with increased complication rates and mortality among patients enrolled in the NCDR implantable cardioverter-defibrillator registry.
    Dewland TA; Pellegrini CN; Wang Y; Marcus GM; Keung E; Varosy PD
    J Am Coll Cardiol; 2011 Aug; 58(10):1007-13. PubMed ID: 21867834
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potential impact of antiarrhythmic drugs versus implantable defibrillators on the management of ventricular arrhythmias: the Midlands trial of empirical amiodarone versus electrophysiologically guided intervention and cardioverter implant registry data.
    Pathmanathan RK; Lau EW; Cooper J; Newton L; Skehan JD; Garratt CJ; Griffith MJ
    Heart; 1998 Jul; 80(1):68-70. PubMed ID: 9764063
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Comparison of ICD implantations in the United States versus Italy.
    Greenberg SM; Epstein AE; Deering T; Goldman DS; Ghidina M; Neason C; Proclemer A
    Pacing Clin Electrophysiol; 2007 Jan; 30 Suppl 1():S143-6. PubMed ID: 17302692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged?
    Daubert JP; Sesselberg HW; Huang DT
    Am J Geriatr Cardiol; 2006; 15(2):88-92. PubMed ID: 16525221
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rationale and design for programming implantable cardioverter-defibrillators in patients with primary prevention indication to prolong time to first shock (PROVIDE) study.
    Saeed M; Razavi M; Neason CG; Petrutiu S
    Europace; 2011 Nov; 13(11):1648-52. PubMed ID: 21784746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Proportion of patients followed in a specialized heart failure clinic needing an implantable cardioverter defibrillator as determined by applying different trial eligibility criteria.
    Toma M; McAlister FA; Ezekowitz J; Kimber S; Gulamhusein S; Pantano A; Sivakumaran S; Cujec B; Paterson I; Armstrong PW
    Am J Cardiol; 2006 Mar; 97(6):882-5. PubMed ID: 16516594
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lack of current implantable cardioverter defibrillator guidelines application for primary prevention of sudden cardiac death in Latin American patients with heart failure: a cross-sectional study.
    Gonzalez-Zuelgaray J; Pellizon O; Muratore CA; Oropeza ES; Rabinovich R; Ramos JL; Tentori MC; Reyes N; Aguayo R; Marin J; Peterson BJ
    Europace; 2013 Feb; 15(2):236-42. PubMed ID: 22968848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.